Painting a new landscape for early-stage melanoma
Panelists will explore in-depth diagnostic and therapeutic advancements, as well as relevant clinical trials.
F025 – The Changing Landscape of Early-Stage Melanoma Management
9-11 a.m. | Saturday, March 8
Room W314B
“Early-stage melanomas — those that are confined to the skin on initial presentation — are a common issue in many dermatology practices, and we as dermatologists are often primarily responsible for directing their management,” said Michael Ming, MD, FAAD, associate professor of dermatology at the University of Pennsylvania. Dr. Ming will lead the Saturday, March 8, session, F025 – The Changing Landscape of Early-Stage Melanoma Management.
“The speakers will focus on new information,” Dr. Ming said. “There will be a melanoma literature update, a discussion of how concerned we should be about potential melanoma overdiagnosis, tips for how to identify which patients should be referred for germline genetic testing, a discussion of histopathologic stains that are helpful — and not helpful — when making melanoma diagnoses, and a discussion of emerging considerations if a patient has a thicker melanoma.”
The session will give attendees the information they need to incorporate this new knowledge into their practice, and relevant clinical trials will also be discussed. Other speakers scheduled to appear are Emily Y. Chu, MD, PhD, FAAD; Rebecca I. Hartman, MD, MPH, FAAD; John Miura, MD; and Kelly C. Nelson, MD, FAAD.
“Recent discoveries and changes in the field may affect how we think of and take care of these early-stage patients, and this session will help dermatologists have the latest information to assist their patients. It should be a wonderful and informative session,” said Dr. Ming.
